Viewing Study NCT01476995


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-01-06 @ 11:48 AM
Study NCT ID: NCT01476995
Status: COMPLETED
Last Update Posted: 2011-11-22
First Post: 2011-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prognostic Indicators as Provided by the EPIC ClearView
Sponsor: Epic Research & Diagnostics, Inc.
Organization:

Study Overview

Official Title: Prognostic Indicators as Provided by the EPIC ClearView
Status: COMPLETED
Status Verified Date: 2011-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GBMC
Brief Summary: The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with known diagnoses identified by medical doctors. Specifically, the investigators hypothesize that the organ system involving any of a series of known active diagnoses will be identified in the EPIC ClearView Response Scale report with the intention of providing potential triage capabilities.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: